Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de AIM ImmunoTech Inc?

Accepted Answer

Según el último estado financiero (Form-10K), AIM ImmunoTech Inc tiene un total de activos de $8, una ganancia neta loss de $-17

Question 2

¿Cuáles son los ratios financieros clave para AIM?

Accepted Answer

El ratio corriente de AIM ImmunoTech Inc es 0.88, el margen neto es 0, las ventas por acción son $0.

Question 3

¿Cómo se desglosan los ingresos de AIM ImmunoTech Inc por segmento o geografía?

Accepted Answer

AIM ImmunoTech Inc largest revenue segment is Ampligen and Other Drugs, at a revenue of 170,000 in the most earnings release.For geography, United States is the primary market for AIM ImmunoTech Inc, at a revenue of 170,000.

Question 4

¿Es rentable AIM ImmunoTech Inc?

Accepted Answer

no, según los últimos estados financieros, AIM ImmunoTech Inc tiene una ganancia neta loss de $-17

Question 5

¿Tiene AIM ImmunoTech Inc alguna deuda?

Accepted Answer

yes, AIM ImmunoTech Inc tiene una deuda de 9

Question 6

¿Cuántas acciones en circulación tiene AIM ImmunoTech Inc?

Accepted Answer

AIM ImmunoTech Inc tiene un total de acciones en circulación de 0.65

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0
Selling, General & Admin	11	14	21	13	8	8
Research & Development	4	5	10	6	7	5
Operating Expenses	16	19	32	20	16	14
Other Non Operating Income (Expenses)	--	--	--	0	0	0
Pretax Income	-16	-17	-28	-19	-19	-14
Income Tax Expense	--	--	--	--	--	--
Net Income	-16	-17	-28	-19	-19	-14
Net Income Growth	-43%	-39%	47%	0%	36%	56%
Shares Outstanding (Diluted)	0.75	0.56	0.48	0.48	47.34	31.84
Shares Change (YoY)	-99%	15%	1%	-99%	49%	774%
EPS (Diluted)	-21.29	-30.91	-59.61	-40.47	-0.4	-0.45
EPS Growth	3,917%	-48%	47%	9,917%	-11%	-82%
Free Cash Flow	-11	-14	-21	-16	-14	-10
Free Cash Flow Per Share	-14.48	-24.99	-43.21	-33.29	-0.29	-0.31
Gross Margin	0%	0%	0%	0%	0%	0%
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-16	-19	-31	-19	-17	-15
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-16	-19	-31	-19	-17	-15
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

AIM ImmunoTech Inc (AIM) Price

AIM Stock Price Chart

AIM Income

Follow-Up Questions